TVTX

TVTX Operating Income Growth

76.51%TTM

Period ending:

TVTX TTM Operating Income YoY %%
TVTX TTM Operating Income YoY %22371.82%-207581.03%
2010-05-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

TVTX operating income growth history

Year-over-year operating income growth rate. The available trailing twelve months (ttm) series contains 64 observations from May 31, 2010 to Jun 30, 2026.

Travere Therapeutics Inc Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
76.5066%
74.8194%
80.5612%
73.6066%
54.8848%
45.8661%
10.1458%
-0.4653%
-14.3891%
-41.8082%
-32.2512%
-36.2203%
-65.6865%
-72.3611%
-68.1179%
-8.2226%
8.806%
17.9155%
8.1736%
-204.5448%
-141.2317%
-98.7692%
-37.4885%
32.957%
20.6148%
-4.5966%
-60.0825%
-26.5394%
-76.7243%
-75.1566%
-48.7981%
-58.7585%
2.0165%
11.0064%
7.5978%
-2.9712%
-20.3905%
-26.8216%
-14.9828%
-1.5881%
3.4229%
28.4601%
36.562%
24.9192%
-5.924%
-83.4866%
-232.9195%
-478.5579%
-635.0888%
-1,611.4715%
-185,327.5294%
-97,733.6566%
-55,170.8264%
-16,858.0038%
1.6658%
3.2905%
18.4486%
33.1779%
-384.444%
-1,336.6698%
-1,730.4695%
118.3166%
104.9399%
105.4634%

Compare operating income growth

All TVTX financial metrics · TVTX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.